Percutaneous Tricuspid Valve Repair.

Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternative solution for such patients since they represent a valid alternative to open heart surgery without the significant risks carried by surgery. A number of percutaneous devices are currently under clinical development. This review will discuss about the latest development in the field of percutaneous tricuspid valve repair with possible future developments.

Informations de copyright

Copyright: © 2022 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

Antonio Mangieri is serving as one of the Editorial Board Members and Guest Editors of this journal. Azeem Latib is serving as one of the Guest Editors of this journal. We declare that Antonio Mangieri and Azeem Latib had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Gaston Rodriguez-Granillo. Dr Mangieri has received a research grant (to the institution) from Boston Scientific and has served on a medical advisory board for Boston Scientific. Dr Latib has served on advisory boards for Medtronic and Abbott; and has been a consultant to Edwards Lifesciences. Other authors have no relevant conflicts of interest.